BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21465572)

  • 1. Redox modulation of p53: mechanisms and functional significance.
    Kim DH; Kundu JK; Surh YJ
    Mol Carcinog; 2011 Apr; 50(4):222-34. PubMed ID: 21465572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells.
    Puca R; Nardinocchi L; Givol D; D'Orazi G
    Oncogene; 2010 Aug; 29(31):4378-87. PubMed ID: 20514025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of DNA damage recognition and nucleotide excision repair: another role for p53.
    Ford JM
    Mutat Res; 2005 Sep; 577(1-2):195-202. PubMed ID: 15927209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 and Delta Np63 alpha differentially bind and regulate target genes involved in cell cycle arrest, DNA repair and apoptosis.
    Schavolt KL; Pietenpol JA
    Oncogene; 2007 Sep; 26(42):6125-32. PubMed ID: 17404570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-translational modification of p53 and the integration of stress signals.
    Meek DW
    Pathol Biol (Paris); 1997 Dec; 45(10):804-14. PubMed ID: 9769944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling to p53: breaking the posttranslational modification code.
    Appella E; Anderson CW
    Pathol Biol (Paris); 2000 Apr; 48(3):227-45. PubMed ID: 10858956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The subcellular distribution of the p53 tumour suppressor, and organismal ageing.
    Wesierska-Gadek J; Schmid G
    Cell Mol Biol Lett; 2005; 10(3):439-53. PubMed ID: 16217555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 modulation of the DNA damage response.
    Helton ES; Chen X
    J Cell Biochem; 2007 Mar; 100(4):883-96. PubMed ID: 17031865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor suppressor gene p53: mechanisms of action in cell proliferation and death].
    Mendoza-Rodríguez CA; Cerbón MA
    Rev Invest Clin; 2001; 53(3):266-73. PubMed ID: 11496714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-translational modifications of p53 tumor suppressor: determinants of its functional targets.
    Taira N; Yoshida K
    Histol Histopathol; 2012 Apr; 27(4):437-43. PubMed ID: 22374721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative binding of p53 to its promoter and DNA recognition elements.
    Weinberg RL; Veprintsev DB; Bycroft M; Fersht AR
    J Mol Biol; 2005 May; 348(3):589-96. PubMed ID: 15826656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation-acetylation interplay activates p53 in response to DNA damage.
    Ivanov GS; Ivanova T; Kurash J; Ivanov A; Chuikov S; Gizatullin F; Herrera-Medina EM; Rauscher F; Reinberg D; Barlev NA
    Mol Cell Biol; 2007 Oct; 27(19):6756-69. PubMed ID: 17646389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selenium compounds regulate p53 by common and distinctive mechanisms.
    Smith ML; Lancia JK; Mercer TI; Ip C
    Anticancer Res; 2004; 24(3a):1401-8. PubMed ID: 15274301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P53 regulation and function in normal cells and tumors.
    Liu Y; Kulesz-Martin M
    Medicina (B Aires); 2000; 60 Suppl 2():9-11. PubMed ID: 11188940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TR-FRET biochemical assays for detecting posttranslational modifications of p53.
    Dudek JM; Horton RA
    J Biomol Screen; 2010 Jun; 15(5):569-75. PubMed ID: 20400726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model for p53-induced apoptosis.
    Polyak K; Xia Y; Zweier JL; Kinzler KW; Vogelstein B
    Nature; 1997 Sep; 389(6648):300-5. PubMed ID: 9305847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living with p53, dying of p53.
    Aylon Y; Oren M
    Cell; 2007 Aug; 130(4):597-600. PubMed ID: 17719538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deacetylation of p53 after nerve growth factor treatment in PC12 cells as a post-translational modification mechanism of neurotrophin-induced tumor suppressor activation.
    Vaghefi H; Neet KE
    Oncogene; 2004 Oct; 23(49):8078-87. PubMed ID: 15361854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [TP53 tumor suppressor gene: 20 years (and ten thousand mutations) later].
    Hainaut P
    Bull Cancer; 2000 Jan; 87(1):11-8. PubMed ID: 10673626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.